Palo Alto Investors LP Aclaris Therapeutics, Inc. Transaction History
Palo Alto Investors LP
- $626 Million
- Q4 2024
A detailed history of Palo Alto Investors LP transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Palo Alto Investors LP holds 569,832 shares of ACRS stock, worth $945,921. This represents 0.23% of its overall portfolio holdings.
Number of Shares
569,832
Previous 569,832
-0.0%
Holding current value
$945,921
Previous $643,000
119.75%
% of portfolio
0.23%
Previous 0.09%
Shares
1 transactions
Others Institutions Holding ACRS
# of Institutions
106Shares Held
87.8MCall Options Held
293KPut Options Held
124K-
Bml Capital Management, LLC Zionsville, IN14.3MShares$23.7 Million21.95% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.63MShares$16 Million0.04% of portfolio
-
Vivo Capital, LLC Palo Alto, CA8.89MShares$14.8 Million4.3% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD6.2MShares$10.3 Million0.61% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.67MShares$7.75 Million0.19% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $111M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...